Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis
about
Dissecting demyelinationRole of platelets in neuroinflammation: a wide-angle perspectiveGene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoidsNeuroinflammatory imaging biomarkers: relevance to multiple sclerosis and its therapy.Gray matters in multiple sclerosis: cognitive impairment and structural MRI.Texture analysis: a review of neurologic MR imaging applications.Flow cytometric analysis reveals the high levels of platelet activation parameters in circulation of multiple sclerosis patients.Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier.In vitro cerebrovascular modeling in the 21st century: current and prospective technologies.Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activityFeasibility of imaging myelin lesions in multiple sclerosisPreclinical detection of infectivity and disease-specific PrP in blood throughout the incubation period of prion diseaseCleavage of myelin associated glycoprotein by matrix metalloproteinases.Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS.Sugammadex, a neuromuscular blockade reversal agent, causes neuronal apoptosis in primary cultures.Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders.Extracellular vesicle protein levels are related to brain atrophy and cerebral white matter lesions in patients with manifest vascular disease: the SMART-MR study.The blood-brain barrier: an engineering perspective.The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases.Compromised blood-brain barrier permeability: novel mechanism by which circulating angiotensin II signals to sympathoexcitatory centres during hypertension.Manganese-Enhanced Magnetic Resonance Imaging as a Diagnostic and Dispositional Tool after Mild-Moderate Blast Traumatic Brain InjuryATROSAB, a humanized antagonistic anti-tumor necrosis factor receptor one-specific antibodyMatrix Metalloproteinases as a Pleiotropic Biomarker in Medicine and Biology.A Role for the Cavin-3/Matrix Metalloproteinase-9 Signaling Axis in the Regulation of PMA-Activated Human HT1080 Fibrosarcoma Cell Neoplastic Phenotype.Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide.Netrin-1 and multiple sclerosis: a new biomarker for neuroinflammation?Prediction of hemorrhagic transformation in acute ischemic stroke using texture analysis of postcontrast T1-weighted MR images.Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption.Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury.Ultra-small superparamagnetic iron oxide enhancement is associated with higher loss of brain tissue structure in clinically isolated syndrome.Fingolimod reduces circulating tight-junction protein levels and in vitro peripheral blood mononuclear cells migration in multiple sclerosis patientsThe "Frail" Brain Blood Barrier in Neurodegenerative Diseases: Role of Early Disruption of Endothelial Cell-to-Cell Connections
P2860
Q22337228-00CD9507-6961-42F3-8125-E63DC3501C79Q28393808-BDED5E04-C143-4BE2-8538-4143ACEF5304Q28647160-448D7568-8508-4B5F-BCC6-E26904C0C4ADQ30576477-ACEA73C9-EDE6-4650-A7FA-AF34BB4B8A12Q30768942-EB14F883-DFBA-4BD9-926C-EACDF1D055E6Q33556336-35646EC6-A09D-4749-943B-11EAC7233289Q33705173-04F8280A-8AAF-42AE-A68A-06A14B3CC0F6Q33842137-C8B02D09-A635-4B39-AFAE-83F301664D4EQ34476565-7BDA8875-7E7B-459C-B633-4B6EC071D9BBQ34999439-C6548C39-D320-407A-85B6-4FD91E956128Q35168009-ECEA0C03-34CF-434A-8650-BADDFB24ED8FQ36343836-7D51E032-ED91-4ADB-B1E3-7B6E95B7BCDEQ36513220-FF3DE366-A9FA-4A8B-A049-2FD13B871C52Q36775309-05FFEABE-811A-4737-99DE-A9FF4C3FDA31Q37119299-7AA23737-DDE8-4FA2-9EC2-625438145366Q37456857-2F436F4E-2BB9-4493-B27C-B5F3C69C7496Q37517034-87377E64-4428-45E6-A708-5DE0BB853F85Q38134725-52E42E2E-F7DC-4D36-93D0-CFEC243978C2Q38322773-F669EA93-E73E-4088-995C-B1ECCCC98A22Q38637276-600C3A3E-F908-49C5-896E-71104F326D23Q40022752-44DD90E5-3485-4FCF-9E16-765F8472C878Q41504457-E35C77AE-9C55-425B-A649-B80A02293F18Q42364466-FC14F134-7B68-455C-B44C-353C9F335861Q42470449-9BF1A98A-7B2B-41FE-B347-D23D8A3D64A7Q42574092-7F86628A-F4C7-460E-94D9-F71B188EAA5CQ48176135-F12D38AC-FB81-49D3-AA64-1097AFF4E8A9Q48424458-E336CE4E-A88F-4501-8D10-05C1777B9858Q48493417-872D0047-7FFB-490B-AF6E-08900599B747Q48822291-6533D7A5-1FDB-4F05-A5D0-2D97BF0073C8Q52148173-AB6A3471-1BB7-4DE2-8530-0459FEA84183Q58603651-E8688EA4-C5FB-449A-9B65-811A88DAE15DQ58753178-3C1235BF-FB2B-415D-AB59-F29E1D629FB9
P2860
Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis
@ast
Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis
@en
Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis
@en-gb
Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis
@nl
type
label
Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis
@ast
Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis
@en
Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis
@en-gb
Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis
@nl
altLabel
Biomarkers Indicative of Blood-Brain Barrier Disruption in Multiple Sclerosis
@en
prefLabel
Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis
@ast
Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis
@en
Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis
@en-gb
Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis
@nl
P921
P3181
P356
P1433
P1476
Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis
@en
P304
P3181
P356
10.1155/2006/709869
P407
P577
2006-01-01T00:00:00Z